A new trading day began on Monday, with Processa Pharmaceuticals Inc (NASDAQ: PCSA) stock price up 4.49% from the previous day of trading, before settling in for the closing price of $0.2. PCSA’s price has ranged from $0.15 to $3.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 22.65% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 81.52%. With a float of $22.73 million, this company’s outstanding shares have now reached $26.19 million.
In an organization with 10 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Processa Pharmaceuticals Inc (PCSA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Processa Pharmaceuticals Inc is 13.24%, while institutional ownership is 0.65%. The most recent insider transaction that took place on Jan 27 ’25, was worth 9,889. In this transaction Director of this company bought 12,400 shares at a rate of $0.80, taking the stock ownership to the 12,400 shares. Before that another transaction happened on Jan 27 ’25, when Company’s Chief Executive Officer bought 87,200 for $0.80, making the entire transaction worth $69,542. This insider now owns 87,200 shares in total.
Processa Pharmaceuticals Inc (PCSA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 81.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.13% during the next five years compared to 22.65% growth over the previous five years of trading.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Trading Performance Indicators
Here are Processa Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.08, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Processa Pharmaceuticals Inc (PCSA)
Let’s dig in a bit further. During the last 5-days, its volume was 8.75 million. That was inferior than the volume of 9.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 3.36%.
During the past 100 days, Processa Pharmaceuticals Inc’s (PCSA) raw stochastic average was set at 8.66%, which indicates a significant increase from 2.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 239.07% in the past 14 days, which was higher than the 134.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2618, while its 200-day Moving Average is $0.7197. However, in the short run, Processa Pharmaceuticals Inc’s stock first resistance to watch stands at $0.2141. Second resistance stands at $0.2233. The third major resistance level sits at $0.2298. If the price goes on to break the first support level at $0.1984, it is likely to go to the next support level at $0.1919. Assuming the price breaks the second support level, the third support level stands at $0.1827.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Key Stats
With a market capitalization of 5.37 million, the company has a total of 11,884K Shares Outstanding. Currently, annual sales are 0 K while annual income is -11,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,830 K.